InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
6
T+90 hit rate
50%
T+90 mean return
+6.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by DeLuca Teresa, Director. Officer active across 4 companies, notably Surgery Partners, Inc.. Aggregated, 20 disclosures have been logged. Split: 5 buys · 6 sells. Total volume traded: €2m. Activity tracked since 8 June 2021. The latest transaction was disclosed on 18 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to DeLuca Teresa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
11,250 shares@ US$14.33Common StockSEC:0001638833-26-000081:0
Canonical exit: 16 Nov 2026 (T+90)
10,000 shares@ US$14.350.0078% mcap5.5% of flowCommon StockSEC:0001638833-26-000079:0
Canonical exit: 16 Nov 2026 (T+90)
7,500 shares@ US$12.680.0020% mcap100.0% of flowCommon StockSEC:0001193125-26-355681:0
20,441 shares@ US$12.23Common StockSEC:0001193125-26-352699:0
17,746 shares0Common StockSEC:0001193125-26-297802:0
11,670 shares@ US$13.710.0076% mcap6.6% of flowCommon StockSEC:0001638833-26-000058:0
20,018 shares@ US$22.7418.3% of flowCommon StockSEC:0001638833-25-000145:0
35,714 shares0Common StockSEC:0000950170-25-086458:0
6,861 shares@ US$23.328.0% of flowCommon StockSEC:0001638833-25-000113:0
35,211 shares0Common StockSEC:0000950170-24-102377:0
36,363 shares0Common StockSEC:0000950170-24-101078:0
6,170 shares@ US$25.937.5% of flowCommon StockSEC:0001638833-24-000121:0
4,192 shares@ US$38.167.6% of flowCommon StockSEC:0001638833-24-000095:0
20,000 shares@ US$24.5024.3% of flowCommon StockSEC:0001638833-22-000137:0
Canonical exit: 19 Feb 2023 (T+90)
4,030 shares@ US$39.707.1% of flowCommon StockSEC:0001638833-22-000111:0
1,535 shares@ US$53.503.5% of flowCommon StockSEC:0001638833-22-000081:0
5,000 shares@ US$4.00100.0% of flowCommon StockSEC:0001213900-21-064878:0
Canonical exit: 9 Mar 2022 (T+90)
2,000 shares@ US$46.703.7% of flowCommon StockSEC:0001638833-21-000138:0
Canonical exit: 8 Nov 2021 (T+90)
5,035 shares@ US$63.6712.3% of flowCommon StockSEC:0001638833-21-000130:0
2,633 shares@ US$63.056.4% of flowCommon StockSEC:0001638833-21-000128:0
20 of 20 declarations
About DeLuca Teresa
DeLuca Teresa is Administrateur and a director of Surgery Partners, Inc., LifeStance Health Group, Inc. and 180 Life Sciences Corp. She has 16 filings in total, and across the 16 sampled filings, buy and sell amounts are EUR 571603 and EUR 865948, with filings ranging from 2021-06-09 to 2026-07-07. The most frequent transaction nature is Attribution.
